ClinicalTrials.gg
RecruitingNCT06225245Updated Oct 26, 2026

Augmenting Upper Limb Function and Functional Neuroplasticity Using Epidural Stimulation of the Cervical Spinal Cord

An interventional study of Epidural Spinal Stimulation (ESS) and Upper extremity rehabilitation in Spinal Cord Injuries, Cervical Spinal Cord Injury and Spinal Cord Injury, sponsored by The Methodist Hospital Research Institute. Recruiting at 1 site in United States. Open to participants aged 22 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by The Methodist Hospital Research Institute · Not applicable, Interventional, and Device feasibility

How we know

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 3 months later.
Updated Oct 26, 2026Primary completion movedStudy completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
22 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 968 studies in Spinal Cord Injuries with a site in United States — 249 open to participants now, 308 under way, 7 of them phase 3. Spinal Cord Injuries · United States.

Planned enrollment
597th of 836
12 · median 24
Started
2024
with 51 others
No phase
601 of 968
189 open now
Primary completion
2029-01
later than 259 of 307 live
Registered
799th of 968
by date

Among the 968 studies in Spinal Cord Injuries with a site in United States, this one is the 597th largest by planned enrollment of the 836 interventional ones that give a count, is one of 52 that started in 2024, is one of 601 with no phase, reaches primary completion later than 259 of the 307 other live ones, and was the 799th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

249 of the 968 studies in Spinal Cord Injuries with a site in United States are open now. Recruiting first, the newest first:

244 more — sign in →

All 249 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 22 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 968 studies in Spinal Cord Injuries with a site in United States, or all of them as a file.
02

Study summary

This study will test whether spinal stimulation combined with rehabilitation can improve arm and hand function in people with tetraplegia after spinal cord injury. Tetraplegia causes weakness or paralysis in the arms and legs.

The stimulation sends electrical pulses through a paddle placed near the spinal cord in the neck. Researchers will study changes in arm and hand function and how the brain and spinal cord respond.

The study has two phases.

**Phase 1: Initial testing**

Participants will:

  • Complete screening to see whether they qualify.
  • Have surgery to place a stimulation paddle in the neck, with wires extending outside the body.
  • Take part in arm and hand exercises with spinal stimulation.
  • Complete tests to measure their response.

The study team will check whether each participant meets the criteria to continue. Those who qualify may choose to enter Phase 2. Those who do not qualify will have the paddle and external wires removed and will not enter Phase 2.

**Phase 2: Permanent implant** Participants will have surgery to implant a battery that powers the stimulation system. They will continue arm and hand exercises with stimulation. The study team will adjust the settings to support each participant's movement goals.

Read the detailed description

Previous research suggests that epidural spinal stimulation (ESS) can activate nerve networks below a spinal cord injury. This feasibility study will examine the safety and potential effects of cervical ESS, delivered near the spinal cord in the neck, combined with arm and hand rehabilitation.

The study has two aims:

  1. Assess changes in arm and hand movement and sensation when cervical ESS is paired with rehabilitation.
  2. Examine how cervical ESS affects brain and spinal cord activity and whether these responses relate to arm and hand function.

Researchers will monitor side effects, skin health, vital signs, and comfort during stimulation.

The study will use several methods to assess changes:

  • Nervous system testing, including brain MRI scans and recordings of electrical signals from the spinal cord.
  • Three-dimensional cameras and sensors to measure arm, hand, and other joint movements.
  • Standardized tests and questionnaires to assess arm and hand function and the ability to perform daily activities.
03

Conditions studied

  • Spinal Cord Injuries
  • Cervical Spinal Cord Injury
  • Spinal Cord Injury

Keywords

  • spinal stimulation
  • epidural spinal stimulation
  • neuromodulation
  • upper extremity function
  • Spinal cord injury
  • Tetraplegia
  • Upper limb function
  • Arm and hand function
  • Spinal cord electrophysiology
04

Who can participate

The criteria were revised on the registry on Oct 26, 2026. See what changed

Ages eligible
22 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed stable medical condition for participation by study physician.
  • Male or female aged 22 - 70 years old.
  • Must provide documentation from personal primary treating physician that reports stable medical condition.
  • Able to passively range bilateral upper extremities within normal mobility parameters as defined by study protocol
  • Maintain current oral anti-spasticity regimen/dosage as approved by study physician with no change in regular use that may affect study outcomes.
  • Six (6) months to 20 years post spinal cord injury.
  • Non-progressive spinal cord injury.
  • Chronic spinal cord injury classified as ASIA Impairment Scale (AIS) grade A, B, or C.
  • Neurological level of injury above T2.
  • Eligible for fMRI per safety questionnaire.
  • Women of must agree to the use of an effective means of avoiding pregnancy for the duration of the study

Exclusion criteria

Exclusion Criteria:

  • Currently involved in another rehabilitation training study.
  • Lower motor neuron injury revealed in the upper limbs.
  • Stabilization hardware in the cervical spine, preventing implantation of ESS system.
  • Active pressure sores, wounds, unhealed bone fractures, peripheral neuropathies, or painful musculoskeletal dysfunction (including contractures in the upper and lower extremities).
  • Any ongoing medical condition which would preclude participant from regular physical activity (including but not limited to: ventilator dependence, cardiopulmonary disease, uncontrollable autonomic dysreflexia or orthostatic hypotension, or active urinary tract infections).
  • Intrathecal baclofen pump therapy for spasticity.
  • Botox injections to primary upper extremity and trunk musculature within the past 3 months which would result in absence of muscle tone and thus preclude response to electrical stimulation therapy.
  • Current or history of neuromuscular conditions (including but not limited to: unhealed ligament of muscle tears in the upper or lower extremities, pain in weight bearing positions for upper and lower extremities).
  • Current or history of seizures or cerebral lesions.
  • depression, psychiatric disorders, or ongoing drug abuse.
  • Currently taking tricyclic anti-depressants, selective serotonin reuptake inhibitors (SSRIs), serotonin nor-epinephrine reuptake inhibitors (SNRI), or bupropion (Wellbutrin).
  • Any reason the PI or treating physician may deem as harmful to the participant or inappropriate for the participant to enroll or continue in the study.
  • (BMI) over 30.
  • Pregnancy or nursing.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Epidural Spinal Stimulation (ESS)

    Participants receive an initial cervical paddle implant and arm and hand rehabilitation paired with stimulation. Those who meet the protocol's response criteria may choose to receive a permanent battery implant and continue rehabilitation with stimulation. Nonresponders have the paddle and external wires removed.

    Device: Epidural Spinal Stimulation (ESS) · Behavioral: Upper extremity rehabilitation

Interventions

  • DeviceEpidural Spinal Stimulation (ESS)

    An implanted paddle array delivers electrical stimulation near the spinal cord in the neck. Settings are adjusted to each participant's tolerance and arm and hand movement goals. Only trained study staff operate the stimulation controller. For participants receiving a permanent implant, home stimulation programs are established and refined before study completion.

  • BehavioralUpper extremity rehabilitation

    Participants complete arm and hand rehabilitation paired with cervical epidural spinal stimulation to work toward their movement goals.

06

What researchers measure

Primary outcomes

  1. Primary Objective

    Primary objectives are to evaluate safety and to quantify the neurophysiological and functional effects of ESS in individuals with SCI. Safety endpoints: Adverse events throughout the study; wound/skin condition; vital signs; pain and spasticity assessments. Neurophysiological and functional endpoints: electrophysiological assessments; MRI; functional assessments measuring 3D kinematics to access major joint and body segment assessments; spinal signals.

    Time frame: Safety: each visit from consent through last visit at week 17, for a total of 17 weeks; then re-assessed monthly after study completion for a period of 12 months. Other: before and after temporary and permanent phases, within 17 weeks of study duration.

Secondary outcomes

  1. Secondary Objective

    The secondary objectives are to evaluate the effects of upper extremity rehabilitation paired with ESS on specific arm and hand functions as well as daily activities. Endpoints: standardized functional and clinical outcomes looking at upper extremity function and effects on daily living.

    Time frame: Before and after temporary and permanent phases, within 17 weeks of study duration

  2. Tertiary/Exploratory

    The exploratory objective is to compare delayed (carry-over) effects following upper extremity rehabilitation training combined with ESS.

    Time frame: Up to 52 weeks after study ends

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is currently no plan to share individual participant data from this study with other researchers.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Jan 2029, 52 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 52 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 26, 2026: primary completion Jan 2027 → Jan 2029 and completion Jan 2027 → Jan 2030.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2023
First posted
Jan 25, 2024
StartActual
Aug 6, 2024
Primary completionEst.
Jan 1, 2029was Jan 2027
CompletionEst.
Jan 1, 2030was Jan 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 1, 2027→Jan 1, 2029
Oct 26, 2026
Study completion
Jan 1, 2027→Jan 1, 2030
Oct 26, 2026
Eligibility
Maximum age 65 Years→70 Years; 3 inclusion criteria edited, 1 added, 6 removed; 4 exclusion criteria edited, 2 added
What changed in the criteria
Inclusion criteria
  • RemovedAll participants must provide a signed and dated informed consent form.
  • RemovedStated willingness to comply with all study procedures and availability for the duration of the study.
  • AddedConfirmed stable medical condition for participation by study physician.
  • EditedMale or female aged 22 - 6570 years old.
  • EditedAble to passively range bilateral upper extremities within normal mobility parameters including:as defined by study protocol
  • Removedgreater than 90 degrees of shoulder flexion and 20 degrees of shoulder extension;
  • Removedgreater than 120 degrees of elbow flexion and reach elbow extension of approximately 150 degrees;
  • Removedneutral wrist position reaching a minimum of 70 degrees of movement (between flexion and extension;
  • Removedability to passively flex and extend fingers.
  • EditedChronic SCI with neurologic level ofspinal cord injury classified as defined by ISNCSCI ASIA Impairment Scale (AIS) grade A, B, or C.
Exclusion criteria
  • EditedAny ongoing medical condition which would preclude participant from regular physical activity (including but not limited to: ventilator dependence, cardiopulmonary disease, uncontrollable autonomic dysreflexia or orthostatic hypotension, or active urinary tract infections, pregnant or nursing).
  • EditedMust not have received Botox injections to primary lowerupper extremity and trunk musculature within the past 3 months which would result in absence of muscle tone and thus preclude response to electrical stimulation therapy.
  • EditedCurrent or history of neuromuscular conditions (including but not limited to: unhealed ligament of muscularmuscle tears in the upper or lower extremities, pain in weight bearing positions for upper and lower extremities).
  • AddedCurrent or history of seizures or cerebral lesions.
  • AddedCurrently taking tricyclic anti-depressants, selective serotonin reuptake inhibitors (SSRIs), serotonin nor-epinephrine reuptake inhibitors (SNRI), or bupropion (Wellbutrin).
  • EditedPregnancy or nursing.
Oct 26, 2026
Interventions
Added Behavioral: Upper extremity rehabilitation
Oct 26, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Assessment of Upper Limb Muscle ResponseNow Primary ObjectiveTime frame: Baseline (Week 4), Post Intervention (Week 7), Follow up (Week 10), Follow up (Week 13) → Safety: each visit from consent through last visit at week 17, for a total of 17 weeks; then re-assessed monthly after study completion for a period of 12 months. Other: before and after temporary and permanent phases, within 17 weeks of study duration.
Oct 26, 2026
Secondary outcomes
2 added, 2 removed
What changed in the outcomes
  • AddedSecondary ObjectiveTime frame: Before and after temporary and permanent phases, within 17 weeks of study duration
  • AddedTertiary/ExploratoryTime frame: Up to 52 weeks after study ends
  • RemovedAssessment of Neurological StatusTime frame: Baseline (Week 1), Post Intervention (Week 8), Follow up (Week 16)
  • RemovedAssessment of IndependenceTime frame: Baseline (Week 1), Post Intervention (Week 8), Follow up (Week 16)
Oct 26, 2026
Contact
Study contact changed: j•••@houstonmethodist.org · •••4654→s•••@houstonmethodist.org · •••1706; removed r•••@houstonmethodist.org · •••3770. See the current contact
Oct 26, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • The Methodist Hospital Research Institute · Houston, United StatesContact j•••@houstonmethodist.org · •••4654→s•••@houstonmethodist.org · •••1706
Oct 26, 2026
Title
Augmenting Rehabilitation OutcomesUpper Limb Function and Functional Neuroplasticity Using Epidural Stimulation of the Cervical Spinal Cord
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Primary completion Jan 1, 2027→Jan 1, 2029
    Study completion Jan 1, 2027→Jan 1, 2030
    Eligibility Maximum age 65 Years→70 Years; 3 inclusion criteria edited, 1 added, 6 removed; 4 exclusion criteria edited, 2 added
    What changed in the criteria
    Inclusion criteria
    • RemovedAll participants must provide a signed and dated informed consent form.
    • RemovedStated willingness to comply with all study procedures and availability for the duration of the study.
    • AddedConfirmed stable medical condition for participation by study physician.
    • EditedMale or female aged 22 - 6570 years old.
    • EditedAble to passively range bilateral upper extremities within normal mobility parameters including:as defined by study protocol
    • Removedgreater than 90 degrees of shoulder flexion and 20 degrees of shoulder extension;
    • Removedgreater than 120 degrees of elbow flexion and reach elbow extension of approximately 150 degrees;
    • Removedneutral wrist position reaching a minimum of 70 degrees of movement (between flexion and extension;
    • Removedability to passively flex and extend fingers.
    • EditedChronic SCI with neurologic level ofspinal cord injury classified as defined by ISNCSCI ASIA Impairment Scale (AIS) grade A, B, or C.
    Exclusion criteria
    • EditedAny ongoing medical condition which would preclude participant from regular physical activity (including but not limited to: ventilator dependence, cardiopulmonary disease, uncontrollable autonomic dysreflexia or orthostatic hypotension, or active urinary tract infections, pregnant or nursing).
    • EditedMust not have received Botox injections to primary lowerupper extremity and trunk musculature within the past 3 months which would result in absence of muscle tone and thus preclude response to electrical stimulation therapy.
    • EditedCurrent or history of neuromuscular conditions (including but not limited to: unhealed ligament of muscularmuscle tears in the upper or lower extremities, pain in weight bearing positions for upper and lower extremities).
    • AddedCurrent or history of seizures or cerebral lesions.
    • AddedCurrently taking tricyclic anti-depressants, selective serotonin reuptake inhibitors (SSRIs), serotonin nor-epinephrine reuptake inhibitors (SNRI), or bupropion (Wellbutrin).
    • EditedPregnancy or nursing.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Assessment of Upper Limb Muscle ResponseNow Primary ObjectiveTime frame: Baseline (Week 4), Post Intervention (Week 7), Follow up (Week 10), Follow up (Week 13) → Safety: each visit from consent through last visit at week 17, for a total of 17 weeks; then re-assessed monthly after study completion for a period of 12 months. Other: before and after temporary and permanent phases, within 17 weeks of study duration.
    Secondary outcomes 2 added, 2 removed
    What changed in the outcomes
    • AddedSecondary ObjectiveTime frame: Before and after temporary and permanent phases, within 17 weeks of study duration
    • AddedTertiary/ExploratoryTime frame: Up to 52 weeks after study ends
    • RemovedAssessment of Neurological StatusTime frame: Baseline (Week 1), Post Intervention (Week 8), Follow up (Week 16)
    • RemovedAssessment of IndependenceTime frame: Baseline (Week 1), Post Intervention (Week 8), Follow up (Week 16)
    Interventions Added Behavioral: Upper extremity rehabilitation
    Contact Study contact changed: j•••@houstonmethodist.org · •••4654→s•••@houstonmethodist.org · •••1706; removed r•••@houstonmethodist.org · •••3770. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • The Methodist Hospital Research Institute · Houston, United StatesContact j•••@houstonmethodist.org · •••4654→s•••@houstonmethodist.org · •••1706
    Title Augmenting Rehabilitation OutcomesUpper Limb Function and Functional Neuroplasticity Using Epidural Stimulation of the Cervical Spinal Cord
    + 6 other changes: index terms, verification date, description, conditions, design details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06225245
Responsible party
Sponsor
First posted
Jan 25, 2024
Start date
Aug 6, 2024
Primary completion
Jan 1, 2029 (estimated)
Completion
Jan 1, 2030 (estimated)
Last update
Oct 26, 2026

Study contacts

Dimitry Sayenko
Contact
sayenkolab@houstonmethodist.org
585-507-1706
Dimitry Sayenko, MD, PhD
principal investigator · The Methodist Hospital Research Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion